Share this post on:

Product Name :
HE-S-2

Search keywords :
D18

drugId :
null

Target Vo:
Programmed death-ligand 1

Target Vo Short Name :
PD-L1

Moa_Name:
Anti-Programmed death-ligand 1

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Tsinghua University

Active Company_Name :
Tsinghua University

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Patritumab deruxtecan web
TNMD Antibody Data Sheet
KDM1A Antibody (YA718): KDM1A Antibody (YA718) is a non-conjugated and Mouse origined monoclonal antibody about 93 kDa, targeting to KDM1A (1B2). It can be used for WB assays with tag free, in the background of Human, Mouse, Monkey.

Share this post on:

Author: Betaine hydrochloride